News
YCC Research Publications
Yale Cancer Center has a long history of breakthrough cancer research and is perhaps best known as the institution where cancer chemotherapy and the entire field of cancer drug development was discovered and the very first cancer drug was administered in 1942. Dr. William Gardner's studies on steroid hormones and their role in experimental carcinogenesis added another dimension to our understanding of malignant disease. The first FDA approved selective immunotherapy treatment for any type of cancer, Transimmunization, was also developed at Yale under the direction of Dr. Richard Edelson.